Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Calithera Biosci Com (CALA)

6.1 -0.35 (-5.43%)

04-20 16:00

Open:

6.45

Pre. Close:

6.45

High:

6.5

Low:

6.1

Volume:

432,381

Market Cap:

219M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.515 - 6.547

6.547 - 6.573

Low:

6.015 - 6.057

6.057 - 6.091

Close:

6.042 - 6.105

6.105 - 6.156

Technical analysis  (as of: 2018-04-20 4:28:06 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 7.91     One year: 8.94

Support:

Support1: 5.35    Support2: 4.45

Resistance:

Resistance1: 6.77    Resistance2: 7.65

Pivot:

6.03

Moving Averages:

MA(5): 6.25     MA(20): 6.23

MA(100): 7.84     MA(250): 12.17

MACD:

MACD(12,26): -0.27     Signal(12,26,9): -0.36

%K %D:

%K(14,3): 42.86     %D(3): 43.92

RSI:

RSI(14): 43.69

52-Week:

High: 20.05  Low: 5.35  Change(%): -45.0

Average Vol(K):

3-Month: 62621  10-Days 60201

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CALA has closed below upper band by 43.4%. Bollinger Bands are 50.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CALA's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-20T08:00:00-04:00
3 Things In Biotech, April 19: Let's Talk Genito-Urinary Cancer

2018-04-18T09:15:48-04:00
Premarket Gainers as of 9:05 am (04/18/2018)

2018-04-18T07:16:45-04:00
Calithera's CB-839 Fast Track'd for advanced kidney cancer

2018-04-03T17:36:52-04:00
After Hours Gainers / Losers (04/03/2018)

2018-03-29T11:45:44-04:00
Calithera Biosciences: Financial Inefficiency Makes The Company Less Competitive

2018-03-08T22:18:07-05:00
Calithera Biosciences' (CALA) CEO Susan Molineaux on Q4 2017 Results - Earnings Call Transcript

2018-03-08T16:08:32-05:00
Calithera Biosciences misses by $0.09, beats on revenue

2018-03-07T17:35:33-05:00
Notable earnings after Thursday's close

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

35.84

Shares Float (M)

35.67

% Held by Insiders

0.50

% Held by Institutions

76.90

Shares Short (K)

2487

Shares Short Prior Month (K)

2910

Stock Financials

EPS

-0.850

EPS Est. Current Year

-0.810

EPS Est. Next Year

-1.050

EPS Est. Next Quarter

-0.230

Forward EPS

-1.881

Book Value (p.s.)

1.470

PEG Ratio

-0.06

Profit Margin

Operating Margin

-114.37

Return on Assets (ttm)

-22.5

Return on Equity (ttm)

-27.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.499

Qtrly Earnings Growth

Operating Cash Flow (M)

13.75

Levered Free Cash Flow (M)

18.60

atoplab.com

Valuation

P/E

-7.18

P/E Growth Ratio

-0.05

P/BV

4.15

P/S

276507584.00

P/CF

15.90

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.